Allele-selective CRISPR deletion as a therapy for ACTA1 congenital myopathy
Fields of Study & Subjects
CRISPR and Genetic Engineering
Muscle Physiology and Disorders
Neurogenetic and Muscular Disorders Research
Publication details
- Journal / source
- Therapeutic Innovation Australia
- Publication date
- 17 February 2026
- Language
- EN